US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership
Announcing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical ReportUS biotech Nabla Bio, Japan's Takeda expand AI drug design partnership